Page last updated: 2024-08-25

isoalantolactone and Osteosarcoma

isoalantolactone has been researched along with Osteosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Di, W; Feng, L; Khan, M; Ma, T; Rasul, A; Sui, Y; Sun, M; Yang, L; Zhong, L; Zhu, Q	1

Other Studies

1 other study(ies) available for isoalantolactone and Osteosarcoma

Article	Year
Isoalantolactone inhibits constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in osteosarcoma U2OS cells through mitochondrial dysfunction. Oncology reports, 2014, Volume: 32, Issue:4 Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Mitochondria; NF-kappa B; Osteosarcoma; Reactive Oxygen Species; Sesquiterpenes	2014

Article

Year

Isoalantolactone inhibits constitutive NF-κB activation and induces reactive oxygen species-mediated apoptosis in osteosarcoma U2OS cells through mitochondrial dysfunction.

Oncology reports, 2014, Volume: 32, Issue:4

Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Mitochondria; NF-kappa B; Osteosarcoma; Reactive Oxygen Species; Sesquiterpenes

2014